Predictors of cognitive outcomes in early Parkinson disease patients: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience

Parkinsonism and Related Disorders

Volumn 16, Issue 8, 2010, Pages 507-512

  Schneider, Jay S ^a   Elm, Jordan J ^b   Parashos, Sotirios A ^c   Ravina, Bernard M ^d   Galpern, Wendy R ^e  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Struthers Parkinson's Center   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Cognition; FAB; Parkinson's disease; RBANS

Indexed keywords

CREATINE; GPI 1485; MINOCYCLINE; PLACEBO; UBIDECARENONE;

ADULT; AGE; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; FRONTAL ASSESSMENT BATTERY; FUNCTIONAL ASSESSMENT; HUMAN; LETTER NUMBER SEQUENCING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PALLIATIVE THERAPY; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; SENSITIVITY ANALYSIS;

ANTIPARKINSON AGENTS; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NATIONAL INSTITUTES OF HEALTH (U.S.); NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; UNITED STATES;

EID: 77956175996     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.06.001     Document Type: Article

References (30)

1. Brown R.G., Marsden C.D. Cognitive function in Parkinson's disease: from description to theory. Trends Neurosci 1990, 13:21-29.
2. Sawamoto N., Honda M., Hanakawa T., Fukuyama H., Shibasaki H. Cognitive slowing in Parkinson's disease: a behavioral evaluation independent of motor slowing. J Neurosci 2002, 22:5198-5203.
3. Hietanen M., Teräväinen H. Cognitive performance in early Parkinson's disease. Acta Neurol Scand 1986, 73:151-159.
4. Levin B.E., Llabre M.M., Weiner W.J. Cognitive impairments associated with early Parkinson's disease. Neurology 1989, 39:557-561.
5. Cooper J.A., Sagar H.J., Jordan N., Harvey N.S., Sullivan E.V. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991, 114:2095-2122.
6. Owen A.M., James M., Leigh P.N., Summers B.A., Marsden C.D., Quinn N.P., et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992, 115:1727-1751.
7. Olanow C.W., Stern M.B., Sethi K. The scientific and clinical basis for the treatment of Parkinson disease. Neurology 2009, 72(S4):S70-S79.
8. Owen A.M. Cognitive dysfunction in Parkinson's disease: the role of fronto-striatal circuitry. Neuroscientist 2004, 10:525-537.
9. Kulisevsky J. Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs Aging 2000, 16:365-379.
10. Department of Health and Human Services, National Institutes of Health. The 2006 Parkinson's disease research plan, Published online: http://www.ninds.nih.gov/research/parkinsonsweb/PD_Plan_2006.htm.
11. NINDS NET-PD Investigators A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology 2006, 66:664-671.
12. NINDS NET-PD Investigators A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson's disease. Neurology 2007, 68:20-28.
13. Meara J., Mitchelmore E., Hobson P. Use of the GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson's disease and their careers in the community. Age Ageing 1999, 28:35-38.
14. Parashos S.A., Swearingen C.J., Biglan K.M., Bodis-Wollner I., Liang G.S., Ross G.W., et al. Determinants of the timing of symptomatic treatment in early Parkinson disease. Arch Neurol 2009, 66:1099-1104.
15. Fahn S., Elton R.L. Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, 153-164. Macmillan Health Care Information, Florham Park, NJ. S. Fahn, C.D. Marsden, D.B. Calne, M. Goldstein (Eds.).
16. Dubois B., Slachevsky A., Litvan I., Pillon B. The FAB: A frontal assessment battery at bedside. Neurology 2000, 55:1621-1626.
17. Randolf C. RBANS Repeatable battery for the assessment of neuropsychological status: manual 1998, The Psychological Corporation, San Antonio.
18. Wechsler D. Wechsler adult intelligence scale-third edition administration and scoring manual 1997, The Psychological Corporation, San Antonio.
19. Levy G., Tang M.-X., Cote L.J., Louis E.D., Alfaro B., Mejia H., et al. Motor impairment in PD. Relationship to incident dementia and age. Neurology 2000, 55:539-544.
20. Appollonio I., Leone M., Isella V., Piamarta F., Consoli T., Villa M.L., et al. The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci 2005, 26:108-116.
21. Lima C.F., Meirele L.P., Fonesca R., Castro S.L., Garrett C. The Frontal Assessment Battery (FAB) in Parkinson's disease and correlations with formal measures of executive functioning. J Neurol 2008, 255:1756-1761.
22. Letenneur L., Gilleron V., Commenges D., Helmer C., Orgogozo J.M., Dartigues J.F. Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatr 1999, 66:177-183.
23. Stern Y., Gurland B., Tatemichi T.K., Tang M.X., Wilder D., Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. J Am Med Assoc 1994, 271:1004-1010.
24. Le Carret N., Auriacombe S., Letenneur L., Bergua V., Dartigues J.-F., Fabrigoule C. Influence of education on the pattern of cognitive deterioration in AD patients: the cognitive reserve hypothesis. Brain Cogn 2005, 57:120-126.
25. Stern Y. Cognitive reserve. Neuropsychologia 2009, 47:2015-2028.
26. Owen A.M., Sahakian B.J., Semple J., Polkey C.E., Robbins T.W. Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 1995, 33:1-24.
27. Bradley V.A., Welch J.L., Dick D.J. Visuospatial working memory in Parkinson's disease. J Neurol Neurosurg Psychiatr 1989, 52:1228-1235.
28. Postle B.R., Jonides J., Smith E., Corkin S., Growdon J.H. Spatial, but not object, delayed response is impaired in early Parkinson's disease. Neuropsychology 1997, 11:171-179.
29. Postle B.R., Locascio J.J., Corkin S., Growdon J.H. The time course of spatial and object learning in Parkinson's disease. Neuropsychologia 1997, 35:1413-1422.
30. Lewis S.J.G., Dove A., Robbins T.W., Barker R.A., Owen A.M. Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci 2004, 19:755-760.